AKT1 and ovarian carcinoma: This is intriguing given that the ovarian cancer cell lines used in this study possess a PI3KCA mutation [20–22] causing constitutive activation of the PI3K/AKT pathway, which indicates the importance of this pathway and the potential vulnerability caused by its temporary inactivity during mitosis.